Quantitative proteomics analysis of chondrogenic differentiation of C3H10T1/2 mesenchymal stem cells by iTRAQ labeling coupled with on-line two-dimensional LC/MS/MS.
The chondrogenic potential of multipotent mesenchymal stem cells (MSCs) makes them a promising source for cell-based therapy of cartilage defects; however, the exact intracellular molecular mechanisms of chondrogenesis as well as self-renewal of MSCs remain largely unknown. To gain more insight into the underlying molecular mechanisms, we applied isobaric tag for relative and absolute quantitation (iTRAQ) labeling coupled with on-line two-dimensional LC/MS/MS technology to identify proteins differentially expressed in an in vitro model for chondrogenesis: chondrogenic differentiation of C3H10T1/2 cells, a murine embryonic mesenchymal cell line, was induced by micromass culture and 100 ng/ml bone morphogenetic protein 2 treatment for 6 days. A total of 1756 proteins were identified with an average false discovery rate <0.21%. Linear regression analysis of the quantitative data gave strong correlation coefficients: 0.948 and 0.923 for two replicate two-dimensional LC/MS/MS analyses and 0.881, 0.869, and 0.927 for three independent iTRAQ experiments, respectively (p < 0.0001). Among 1753 quantified proteins, 100 were significantly altered (95% confidence interval), and six of them were further validated by Western blotting. Functional categorization revealed that the 17 up-regulated proteins mainly comprised hallmarks of mature chondrocytes and enzymes participating in cartilage extracellular matrix synthesis, whereas the 83 down-regulated were predominantly involved in energy metabolism, chromatin organization, transcription, mRNA processing, signaling transduction, and cytoskeleton; except for a number of well documented proteins, the majority of these altered proteins were novel for chondrogenesis. Finally, the biological roles of BTF3l4 and fibulin-5, two novel chondrogenesis-related proteins identified in the present study, were verified in the context of chondrogenic differentiation. These data will provide valuable clues for our better understanding of the underlying mechanisms that modulate these complex biological processes and assist in the application of MSCs in cell-based therapy for cartilage regeneration.
Ji
Yu-hua
YH
Institute of Tissue Transplantation and Immunology, Key Laboratory of Ministry of Education for Genetic Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. tjiyuhua@office.jnu.edu.cn
Ji
Ju-ling
JL
Sun
Fen-yong
FY
Zeng
Yao-ying
YY
He
Xian-hui
XH
Zhao
Jing-xian
JX
Yu
Yu
Y
Yu
Shou-he
SH
Wu
Wei
W
D000818:Animals; D055396:Bone Morphogenetic Protein 2 / Q000378:metabolism; D002356:Cartilage / Q000378:metabolism; D002454:Cell Differentiation; D002460:Cell Line; D019902:Chondrocytes / Q000737:chemistry* / Q000166:cytology / Q000378:metabolism; D020219:Chondrogenesis; D002853:Chromatography, Liquid; D015536:Down-Regulation; D005109:Extracellular Matrix / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000235:genetics; D020407:Internet; D059630:Mesenchymal Stem Cells / Q000737:chemistry* / Q000166:cytology / Q000378:metabolism; D051379:Mice; D040901:Proteomics; D012333:RNA, Messenger / Q000235:genetics; D011994:Recombinant Proteins / Q000235:genetics; D053719:Tandem Mass Spectrometry; D014157:Transcription Factors / Q000235:genetics*
C550704:BTF3l4 protein, mouse; D055396:Bone Morphogenetic Protein 2; D016326:Extracellular Matrix Proteins; C120769:Fbln5 protein, mouse; D012333:RNA, Messenger; D011994:Recombinant Proteins; D014157:Transcription Factors